Join
Live feed
·
PRReleasevia Quantisnow
Auris Medical Holding Ltd. logo

Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma

ByQuantisnow·Wall Street's wire, on your screen.
EARS· Auris Medical Holding Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EARS (Auris Medical Holding Ltd.) and more on Quantisnow.